CS logo
small CS logo
Hospital General de Alicante

Alicante, Spain
Hospital, Alicante (Alacant)

About Hospital General de Alicante


El Hospital General Universitario de Alicante Doctor Balmis es un hospital público dependiente de la Consejería de Sanidad Universal y Salud Pública de la Generalidad Valenciana situado en la ciudad española de Alicante.​
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at Hospital General de Alicante


During the past decade, Hospital General de Alicante conducted 38 clinical trials. In the 10-year time frame, 38 clinical trials started and 16 clinical trials were completed, i.e. on average, 42.1% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 7 clinical trials were completed. i.e. 58.3% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer
2003-06-01
2006-12-01
Completed
440
DORADO-AC - Optimized Doses of Darusentan as Compared to an Active Control in Resistant Hypertension
2006-09-01
2009-08-01
Completed
849
Cancer Vaccine Study for Unresectable Stage III Non-small Cell Lung Cancer (START)
2007-01-01
2015-04-01
Completed
1,513
Study of Proxinium Plus Best Supportive Care Versus Best Supportive Care for Patients With Advanced Head and Neck Cancer
2005-12-01
2008-04-01
Terminated
165
Phase II Study to Evaluate Efficacy and Safety of RP101 in Combination With Gemcitabine
2007-09-01
2009-10-01
Terminated
153
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
2013-06-27
2020-11-12
Completed
2,877
Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)
2013-07-10
2018-01-18
Completed
6,991
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-03-22
Terminated
16,784

Rows per page:

1–21 of 21

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Hospital General de Alicante" #1 sponsor was "PETHEMA Foundation" with 16 trials, followed by "Spanish Lung Cancer Group" with 7 trials sponsored, "Hoffmann-La Roche" with 5 trials sponsored, "ETOP IBCSG Partners Foundation" with 4 trials sponsored and "Fundación GECP" with 4 trials sponsored. Other sponsors include 50 different institutions and companies that sponsored additional 48 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital General de Alicante" #1 collaborator was "Hoffmann-La Roche" with 4 trials as a collaborator, "ARTTIC International Management Services" with 1 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Amgen" with 1 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 44 different institutions and companies that were collaborators in the rest 54 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Hospital General de Alicante


According to Clinical.Site data, the most researched conditions in "Hospital General de Alicante" are "Acute Lymphoblastic Leukemia" (7 trials), "Coronary Artery Disease" (5 trials), "Non-Small Cell Lung Cancer" (4 trials), "Acromegaly" (3 trials) and "Breast Cancer" (3 trials). Many other conditions were trialed in "Hospital General de Alicante" in a lesser frequency.

Clinical Trials Intervention Types at Hospital General de Alicante


Most popular intervention types in "Hospital General de Alicante" are "Drug" (63 trials), "Device" (11 trials), "Procedure" (8 trials), "Biological" (3 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Carboplatin" (7 trials), "Placebo" (7 trials), "Cyclophosphamide" (6 trials), "Docetaxel" (6 trials) and "Cisplatin" (5 trials). Other intervention names were less common.

Clinical Trials Genders at Hospital General de Alicante


The vast majority of trials in "Hospital General de Alicante" are 83 trials for "All" genders and 8 trials for "Female" genders.

Clinical Trials Status at Hospital General de Alicante


Currently, there are NaN active trials in "Hospital General de Alicante". undefined are not yet recruiting, 14 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 49 completed trials in Hospital General de Alicante, undefined suspended trials, and 13 terminated clinical trials to date.
Out of the total trials that were conducted in Hospital General de Alicante, 1 "Phase 1" clinical trials were conducted, 23 "Phase 2" clinical trials and 30 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 15 trials, and there were also 6 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status